Elevance Health Inc. stock outperforms competitors on strong trading day
Elevance Health Inc. closed 27.50% below its 52-week high of $567.26, which the company achieved on September 3rd.
Elevance Health: Attractive Valuation and Stable Growth Prospects Drive Buy Rating
Whit Mayo, an analyst from Leerink Partners, reiterated the Buy rating on Elevance Health (ELV – Research Report). The associated price target ...
Positive Outlook for Elevance Health Amid Strategic Positioning and Revenue Growth
Analyst David Windley from Jefferies maintained a Buy rating on Elevance Health (ELV – Research Report) and increased the price target to ...
How Is The Market Feeling About Elevance Health?
According to Benzinga Pro, Elevance Health's peer group average for short interest as a percentage of float is 5.53%, which ...
Elevance Health, Inc. (NYSE:ELV) Stock Position Increased by Avior Wealth Management LLC
Avior Wealth Management LLC boosted its position in Elevance Health, Inc. (NYSE:ELV – Free Report) by 10.4% during the 4th quarter, according to the company in its most recent filing with the ...
Insurancenewsnet.com16h
Fifth Third Bancorp Decreases Stock Holdings in Elevance Health, Inc. (NYSE:ELV)
Fifth Third Bancorp cut its holdings in Elevance Health, Inc. (NYSE:ELV - Free Report) by 26.2% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The ...
Canada15h
Public Health Agency of Canada
The Public Health Agency of Canada is part of the federal health portfolio. Our activities focus on protecting against threats to public health, preventing and reducing diseases and injury, and ...